Mithra Pharmaceuticals (CHIX:MITRAB) FCF Margin % : 122.76% (As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mithra Pharmaceuticals's Free Cash Flow for the six months ended in Jun. 2023 was €8.64 Mil. Mithra Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was €7.04 Mil. Therefore, Mithra Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2023 was 122.76%.

As of today, Mithra Pharmaceuticals's current FCF Yield % is -196.13%.

The historical rank and industry rank for Mithra Pharmaceuticals's FCF Margin % or its related term are showing as below:

CHIX:MITRAb' s FCF Margin % Range Over the Past 10 Years
Min: -1065.95 Med: -133.8 Max: -1.79
Current: -45.22

During the past 11 years, the highest FCF Margin % of Mithra Pharmaceuticals was -1.79%. The lowest was -1065.95%. And the median was -133.80%.

CHIX:MITRAb's FCF Margin % is ranked worse than
84.42% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.25 vs CHIX:MITRAb: -45.22

Mithra Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Mithra Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals FCF Margin % Chart

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-11.33

-64.53

-1,065.95

-432.20

-123.11

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															-345.60	-532.08	-400.61	-66.46	122.76

Competitive Comparison of Mithra Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mithra Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mithra Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mithra Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mithra Pharmaceuticals's FCF Margin % falls into.

Mithra Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mithra Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-82.477	/	66.997
	=	-123.11 %

Mithra Pharmaceuticals's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	8.636	/	7.035
	=	122.76 %

Mithra Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany MITRA:Belgium

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines